© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Over the years, folks in chemical research pulled countless sugar derivatives out of their toolkits, looking for new ways to move medicine and industry forward. Potassium sucrose octasulfate grew from this push, after persistent efforts tackling wound healing led scientists to start tinkering with classic sucrose. Early mentions in journals from the twentieth century often revolved around its healing properties, especially after mixing sugar chemistry with the known effects of sulfate salts. Technological advances in organic chemistry labs let researchers create tailored sulfates, including the eight-positioned potassium salt. The steady arc of its development mirrored our growing ability to manipulate molecules and build hybrids, not just for curiosity, but because burns, ulcers, and inflammatory conditions needed better care. The wave of new medicines following World War II helped shine the light wider, propelling potassium sucrose octasulfate through various formulas and applications.
Potassium sucrose octasulfate presents a mouthful for most people, but behind the name lies a compound based on simple building blocks—white crystalline sugar and a blend of sulfates. After combining sucrose with sulfur trioxide and potassium, what emerges is a salt prized for protecting mucous membranes. In some countries, you’ll spot it woven into medicines for peptic ulcers or as a base in wound dressings. Notably, it does much more than form a barrier; studies found it helps repair tissue on the molecular level, which led to more investigations in both human and veterinary medicine. Its significance comes from doing more than just shielding, offering a targeted approach, thanks to its chemical structure, that interacts directly with exposed tissue. Real-world value rises when you ask patients who’ve struggled with recurring gastritis or chronic wounds, and get stories of faster, more comfortable healing.
The compound itself doesn’t look flashy—fine, off-white powder, moderately soluble in water. You can spot its faintly sweet taste if you’re curious, but what matters in day-to-day handling lies in its stability and its robust interaction with proteins at mucosal interfaces. Chemically, eight sulfate groups anchored to a single sucrose ring system match up with potassium ions. This layout creates a negative charge across the molecule that allows for those tissue-binding effects we see in medical use. Potassium as a counterion means you avoid some of the drawbacks of sodium-based salts, like water retention in sensitive patients. While it resists breakdown under ordinary storage, exposure to plenty of moisture can alter its consistency, a hurdle for manufacturers focused on product shelf-life. The importance of its charge distribution and structure makes it unique among the long line of sugar sulfates, standing apart for specific medical outcomes rather than mere laboratory curiosity.
In the pharmacy, you’ll sometimes find potassium sucrose octasulfate listed under other trade names, depending on country and local regulations. Packaging rarely touts flashy branding; what matters more is clear labeling for dosage, usually sorted around product purity and intended application. The purity often needs to meet strict criteria to land in wound-care sections or for licensed use in oral medications. Too much sulfate, or too little potassium, throws off medical results. Industry standards demand that labeling states the precise content of its active ingredient, alongside excipients, and carries warnings about moisture sensitivity. For professional use, guidelines recommend checking batch certificates that detail pH, appearance, and content uniformity. From experience, I know clinicians value transparent labeling: unexpected excipients or unclear measures can affect allergy risks or dosing. Good labeling supports best outcomes when nurses and doctors work under time pressure.
Industry-scale production rarely makes headlines, but the process turns basic chemistry into something life-changing. Producers start with ordinary table sugar, then carefully react it with sulfur trioxide or chlorosulfonic acid under cold, controlled conditions. This yields sucrose octasulfate, which then gets neutralized using potassium hydroxide or carbonate. The resulting slurry passes through filtration and drying steps, then gets milled fine enough for either direct medication use or for blending into pastes and gels. Each stage, from reagent addition to dry powder, holds risks—sulfur trioxide isn’t friendly, and keeping the environment dry stops lump formation and ensures shelf stability. Over the years, refinements made processing safer, with better containment and more sensitive chemical monitors. Setting aside factory ammonia smells and tank cleaning issues, these improvements cut down on accidents and make sure every batch meets strict safety benchmarks.
Potassium sucrose octasulfate offers surprising flexibility on the lab bench. You can spot researchers tweaking the sulfate count or swapping potassium for other cations, chasing new uses or adjusting pharmaceutical profiles. Some labs swap the potassium out for sodium or even calcium, searching for the right salt for skin dressings or specific oral medications. The giant negative charge of this molecule drives most of its chemical reactivity, latching strongly onto proteins, which gives it bioadhesive qualities in clinics. Studies run reactions under different pH ranges to see what breaks down most slowly in body fluids. At high heat or extreme acid, decomposition can yield sulfur dioxides and other gases—those handling risks steer many toward gentler production methods. Changes to its backbone rarely make it past research, since doctors and pharmacists prefer the predictable performance of the classic potassium salt.
In scientific circles, you’ll see potassium sucrose octasulfate listed as potassium octasulphated sucrose or potassium 1,6:3,4:2,3:5,6-tetra-O-(sulfooxy)-D-glucopyranosyl-D-fructofuranoside. Trademarked drug names often shift with region. Hospitals tend to stick with the more formal names, avoiding confusion between different salts or brands. The name game might seem dull but matters a great deal for international supply—mistaking one sulfate for another can throw off treatments, especially when switching from oral to topical use or between adult and pediatric dosing. My experience says most folks just call it "the potassium salt"—a bit of hospital shorthand that shows up in treatment notes and equipment tags.
Occupational safety in handling potassium sucrose octasulfate starts with chemical hygiene and ends with careful monitoring of dust exposure. While the compound itself feels mild, the precursor chemicals pack risks, specifically strong acids and sulfur oxides. On site, workers train with respirators and rubber gloves, and evacuation drills aren’t rare. Regulations in Europe and Asia set firm exposure limits for both final product and side streams. Facilities tune their ventilation systems to catch floating powder, and routine surface testing happens to avoid contamination. Product safety involves clear instructions for clinical staff—accidental inhalation or eye contact, though rare, calls for prompt rinsing, and anyone sensitive to sulfates reads warning labels twice. Hospitals lock up their supplies to keep things out of children’s reach, and pharmacists keep sharp eyes on expiry dates since exposure to humidity weakens potency. When protocols slip, the result isn't just inconvenience but real risk. These checks, dull as paperwork looks, keep staff and patients out of trouble.
Doctors and wound care nurses praise potassium sucrose octasulfate for work in digestive tract ulcers and chronic wound management. It doesn’t replace antibiotics, but forms a tough, almost invisible link with tissue proteins at the site of application. That’s why it lines up in the treatment of mouth sores, skin ulcers from diabetes, and certain burns that resist healing with plain dressings. Results from the trenches—care homes and rehab wards—show patients tolerate this sulfate salt better than some older remedies built from silver or iodine. Hospitals tend to reach for it after other wound-care staples falter, and animal clinics have started mixing it into gels for pets with tough-to-treat sores. The compound’s use in dental gels signals its safety near sensitive tissues, and emerging research sees it as a possible additive in eye drops or new bandage materials. This breadth of application hints at an untapped potential, pushing more R&D teams to experiment with delivery methods, like sprays or films that can reach neglected wounds on elbows, feet, or even tricky spots inside the mouth.
Most research from the last few decades chased two main questions—does potassium sucrose octasulfate speed up tissue healing, and what slows it down? Clinical studies out of Europe showed that patients with chronic leg ulcers healed faster when treated with topical products containing it, compared to traditional wet gauze or hydrogen peroxide. Academic centers picked up the trail, running lab tests on human skin samples, and saw less inflammation along treated wound lines. Researchers at hospitals then teamed up with commercial partners, pushing for new forms: slow-release patches, dissolvable strips, and oral solutions. Animal-based studies took the process further by seeing how this compound affected infection rates and scarring, showing smaller, smoother scar formation in several wound models. Development teams now chase stable formulations—ways to keep the compound potent even after weeks on a hospital shelf or after shipping overseas. The product’s knack for working in harsh environments—heat, humidity, and protein-rich tissue—gives it an advantage over standard wound-care additives. Direct interviews with field researchers suggest the toughest hurdle isn’t effectiveness, but finding cheap, sustainable production methods to keep up with growing demand in both developed and low-resource settings.
Potassium sucrose octasulfate enjoys a record of low toxicity when used as intended on wounds or inside the digestive tract. Scientists track its journey through the body and spot fast excretion through the kidneys, with little buildup in organs. Animal trials found high safety margins—skin irritation and allergic reaction rates line up lower than most antiseptics or wound fillers. On rare occasions, hospital reports turn up itching or mild rash, and some patients with severe sulfate sensitivities steer clear. Oral use passes another hurdle, with few side effects except, on rare occasions, mild stomach upset. That said, no one ignores scale: factory workers get far more exposure, risking the ill effects of airborne dust or accidental splashes with precursor acids. Long-term safety studies in animals suggest cumulative risks run low, making it a smart candidate for new medical technologies, so long as real-world storage and handling stick to established guidelines.
Looking ahead, potassium sucrose octasulfate sits at the intersection of old-school pharmacology and new wound-care tech. R&D leaders target longer-lasting gels for severe bedsores, while startups toy with nanoparticle blends to coax deeper tissue repair. Hospitals in aging countries will lean harder on products that fight slow-healing wounds and minimize scarring. On the food safety front, its strong binding to proteins opened the door for experiments in preserving food-contact surfaces, but regulatory bodies move cautiously. Pharmacy shelves will likely feature upgraded formulations with controlled-release carriers, taking lessons from recent advances in bioadhesive dressings. Scientists setting up clinical trials now focus on underserved populations—diabetic wound patients, cancer survivors, and people with skin diseases that resist regular treatment. As antibiotic resistance rises and hospital budgets tighten, dependable, safe compounds like potassium sucrose octasulfate stand out for steady value and adaptability. New partnerships between biotech firms, universities, and public health groups could lower production costs, pushing this once-niche product into broader use, from military medicine to sports injury clinics, and beyond.
People have always searched for solutions to stubborn wounds and fragile skin. Medical professionals lean into options that help tissue repair and fight infection, especially for those living with challenging conditions like diabetes or chronic ulcers. Potassium sucrose octasulfate steps in as a tool that draws from both science and what patients deal with every day.
Potassium sucrose octasulfate isn’t some brand-new synthetic chemical. Scientists started tinkering with sugars and sulfur groups when they looked for ways to promote healing. They noticed that this compound creates a gentle shield that discourages harmful bacteria from latching onto weak spots. Bacteria have always been a headache for wound recovery—trapping moisture, triggering infection, and slowing the body’s natural mending. By making it harder for these microscopic invaders to stick around, potassium sucrose octasulfate gives the body a much-needed edge.
Pressure ulcers, diabetic foot sores, venous leg ulcers—these are the kind of wounds that stubbornly refuse to heal. Dressing changes and careful cleaning can only do so much. When ulcers keep breaking down, patients face pain, risk of infection, and the constant worry something might spiral out of control. Research across Europe and recent case studies point to potassium sucrose octasulfate as a promising answer for slow-to-heal wounds. Doctors noticed that wounds cleaned and dressed with this compound showed faster healing rates and a lower chance of infection compared to regular care.
Hospital workers and home care nurses apply potassium sucrose octasulfate in gel, powder, or dressing form, usually right onto the wound bed. The material lays down a kind of barrier between the wound and the environment. That shield helps keep the wound moist—without giving bacteria the soggy space they love. Patients report less pain and less foul odor from their wounds, which makes daily life less stressful. These practical benefits often mean fewer trips to the clinic and a break from constant antibiotics.
Some hospitals in Europe have adopted potassium sucrose octasulfate dressings as part of routine protocols for certain ulcers. People outside these regions may have a harder time finding access. Insurance coverage poses another barrier, limiting choices for those who might benefit most. There’s room here for policy shifts and more research. If insurance companies and regulators recognize the broader value—reduced infections, shorter healing time, lower hospital readmission—patents and profits won’t stand in the way for long.
Doctors, patients, and pharmacists need clear information. The medical world buzzes with new treatments all the time, and separating hype from hard evidence isn’t easy. Reliable, peer-reviewed studies can cut through the noise. Anyone facing chronic wounds should ask their healthcare provider about the best available products. People don’t deserve to spend months trapped by the pain and anxiety of unhealed wounds, especially when new science like potassium sucrose octasulfate can tip the odds in their favor.
Doctors and pharmacists often recommend Potassium Sucrose Octasulfate (PSO) for treating certain wounds, ulcers, and skin injuries. It doesn’t get as much attention as some blockbuster drugs, but many people depend on it—especially for chronic skin issues. PSO acts as a protective barrier, keeping wounds moist and limiting bacterial contamination. The value comes not just from what PSO does but how consistently it does it, especially for those who struggle with slow-healing sores.
Having spent years reporting on medical innovations, I find doctors want real-world results, not just laboratory numbers. The best medical evidence comes from years of observation as much as tightly controlled trials. Studies out of Europe show that PSO, both as a gel and as a dressing, helps chronic ulcers heal faster and reduces infections. The European Medicines Agency reviewed safety data spanning over a decade and concluded that most people tolerate PSO well, even those with underlying conditions like diabetes or vascular problems.
Not every compound fits everyone. For patients with kidney disease, potassium levels can become a worry. Extra potassium in the bloodstream sometimes creates problems the longer someone uses the product. This doesn’t mean throw out the treatment—just monitor blood tests. The biggest concern that pops up in forum discussions and published reports is skin irritation. Some users notice redness, rash, or stinging, especially with prolonged use. Allergic reactions seem rare, but they do happen, as with almost anything applied to skin.
Most people using PSO dressings deal with wounds that never seem to go away—pressure ulcers, diabetic foot ulcers, or venous leg ulcers. Using anything daily or weekly for months or years highlights side issues others might miss. In published audits of real patients, infection rates did not spike. No rise in cancer risk ever came up, and no connection turned up between PSO absorption through ulcers and major health events.
Consistent research helps build trust. Reviews like one in the Journal of Wound Care pooled data from hundreds of chronic wound patients. These show low rates of long-term side effects. Regulatory agencies in Europe and parts of Asia have continued to back PSO for routine wound management, based on evidence and absence of major safety signals. Still, the medical community pushes for more robust, long-term studies, particularly for patients with advanced kidney problems or autoimmune skin diseases.
My conversations with wound care nurses reveal another truth: People use whatever keeps the sore clean, dry, and infection-free. If PSO fits that bill without harming the patient over months, it stays in the toolkit. If problems start to show, most clinics adjust the plan quickly. People sometimes get anxious about newer compounds, but so far, PSO looks safer than many older alternatives loaded with silver or iodine, which add their own toxic risks.
The smartest step anyone with a chronic wound—or their caregivers—can take is to check in with a health professional often. Blood work, skin checks, and honest conversations do more to keep patients safe than just reading the label. Potassium Sucrose Octasulfate won’t solve every problem, but careful use and regular follow-up help lower risk. Open communication with your care team about any burning, stinging, or swelling ensures issues get caught early.
Out of all the new names that have surfaced in pharmacy and wound care, Potassium Sucrose Octasulfate stands out, not because it’s flashy, but because doctors count on it to help healing along. Anyone working in a hospital or even caring for someone at home with bedsores or ulcers may have come across this compound. I first saw it during a routine hospital rotation, watching nurses prepare a topical treatment for a patient with a stubborn leg ulcer. Seeing how carefully they measured, mixed, and applied the medication drove home the point that using it right makes all the difference.
Let’s break down what actually happens. In the real world, Potassium Sucrose Octasulfate mostly enters the scene as a topical gel or dressing for wounds. Burns and pressure ulcers can drag on for months if not handled well, so it’s no wonder that a lot of clinical guidelines recommend using this compound for managing those hard-to-heal spots. The rationale isn’t based on hype but on studies showing how this material interacts with wound exudate, forming a protective barrier and helping to regulate the local environment so tissues can knit together. Clinicians choose this method because direct application cuts down on the risk of systemic side effects. There’s little appetite among patients for more pills and more complications.
Nurses and wound specialists start by cleaning the wound gently—nobody wants bacteria sticking around. The gel or dressing then gets put directly onto the raw area. Dressings are changed following a schedule, usually once a day, though patients who sweat a lot or have heavy drainage might need changes more often. Personal experience tells me that communication is key: patients need a heads-up about what sensations (mild tingling, coolness) they might notice once the treatment hits their skin. Anything worse than mild and the patient should let the healthcare team know quickly.
Some folks ask about taking Potassium Sucrose Octasulfate by mouth. Not every drug works well both topically and orally; this is one of those. Swallowing it wouldn’t hit the infection or wound directly. Instead, the direct approach means the full effect gets focused right where the body needs help the most. This also keeps other organs from dealing with more chemicals than absolutely necessary.
While many treatments play catch-up with infection and swelling, Potassium Sucrose Octasulfate punches above its weight. It draws in moisture, helps manage harmful ions at the wound surface, and supports growth of healthy tissue. An open sore on a diabetic foot, for example, sometimes won’t stitch together without a nudge like this. Hard data from published research in wound journals confirms that wounds treated with this topical agent close more quickly than with plain saline or older ointments.
No single compound covers every need. For deep or infected wounds, or in patients with complicated medical histories, the treatment plan involves more than just a gel. Doctors weigh risks and benefits, taking allergies and sensitivities into account. Most people tolerate Potassium Sucrose Octasulfate well, but rare cases of skin irritation happen. If I learned anything from working at bedside, it’s that patients feel more comfortable with clear guidance and regular check-ins.
Ultimately, the right use of Potassium Sucrose Octasulfate means regular, gentle application under medical supervision, good hygiene, and keeping an eye out for any changes. Having protocols in place and educating patients and caregivers closes the loop between science and healing.
Potassium sucrose octasulfate often drops into a conversation for wound care, oral mucositis, or ulcers. It gets recommended because it forms a protective barrier, keeps out irritants, and lets tissues heal. I’ve heard many say it seems gentle, especially compared to some other wound treatments. But even things that heal can bug the body in small ways.
Nausea shows up on the list of complaints from folks using potassium sucrose octasulfate, either as an oral suspension or a topical gel in the mouth. Some mention a strange taste that lingers, almost metallic. Nausea rarely gets too strong, but it lingers enough that people notice when eating or brushing their teeth after taking the medication. Sometimes, mild stomach pain or bloating pops up—you don’t usually see vomiting or bad diarrhea unless someone is sensitive or taking a larger dose.
Based on what’s out there, potassium content can matter. If someone already takes medicines or has kidney concerns, adding more potassium through this compound could start to tip electrolyte balances. Doctors usually steer people on potassium-sparing diuretics or kidney problems toward alternatives. I’ve met patients already tracking their potassium because of blood pressure pills or heart issues, and they double-check with doctors about adding anything extra, even in the name of wound care.
Redness, burning, or mild irritation can hit where the gel touches skin or mucosa. In dental or oral settings, some notice a sting on broken, ulcerated tissue, but they don’t often stop the treatment—usually, that fades as the area heals. Allergic reactions are rare, but not unheard of; those signs look like rashes, swelling, or itching. If you’ve ever reacted to sulfates before, ask your provider before trying this product, and read the ingredients closely.
Beyond statistics, actual stories shape how I look at this issue. Watching someone manage a pressure ulcer at home, scared of infection, means any barrier gel is welcome—but if the medicine makes daily life tougher, maybe through lingering stomach upset, confidence drops. Most folks trade a little discomfort for real healing. But when manufacturers and doctors collect side effect data, it builds better trust—patients want honesty, not hidden surprises.
Doctors usually suggest starting slow, reminding patients to use only the amount needed around wounds or ulcers. Monitoring potassium through blood work can matter for those with kidney or heart issues. If mouth irritation bugs a person, rinsing after use, avoiding spicy foods, and spacing out doses can help. Pharmacists also play a role—they flag drug interactions if someone’s already juggling a long medication list.
Everyone responds differently, especially with something that interacts at the microscopic level as much as it does on the surface. If you notice stomach or skin changes after starting this medicine, don’t tough it out alone. Let healthcare teams know early—adjustments and personal attention work much better than finding out about a rare side effect in the ER.
A lot of people today take more than one medicine. Some get pills for blood pressure, others need heart support, and a handful turn to creams or gels for stomach issues or skin wounds. Potassium sucrose octasulfate (PSO) falls into the group of ingredients used mostly for stomach lining repair or wound healing. I’ve heard from friends who tried something new for their ulcer, only to worry later if it clashed with statins, aspirin, or antacids.
PSO, as the name hints, carries potassium and sulfate groups bound to a sugar. The body doesn’t break down or absorb much of it systemically. That's one reason doctors trust it to guard or rebuild tissue without sending potassium levels through the roof. This ingredient works right at the surface—think of a bandage for your stomach, colon, or skin.
Pharmacists and doctors like to know if a compound blocks or boosts the effect of other drugs. Research shows that PSO, when used as an oral or topical formulation, doesn’t overlap much with other drug processing pathways. It stays mainly where it’s applied. Still, not everything runs so smoothly in real life.
Potassium itself deserves some attention. PSO contains potassium ions, and too much potassium, especially for folks with kidney disease or those on "water pills" or ACE inhibitors, can raise potassium levels. These spikes sometimes don’t show obvious warnings until trouble starts. So, if you already take medicines that hike up potassium (spironolactone, losartan, supplements), always flag this with your doctor.
Besides potassium, PSO preps may interact with medicines if applied together in a wound or inside the digestive tract. For example, it could block absorption of certain antibiotics or heart drugs if smeared over large, open wounds or used as a slurry for ulcers. I’ve seen nurses stagger the timing for anything given by mouth to let PSO do its work first, then let the stomach clear before the next pill.
Clear communication with your physician or pharmacist makes a difference, especially for those who don’t always recall their medicine names. Bring a list, or just put all your pills on the counter and snap a picture for the next doctor visit.
Always ask about timing. Should PSO go in the morning or night? Before or after that little white BP pill? Timing cuts down the chance of one medication interfering with another, especially for older adults with slower stomach emptying.
Lab checks matter too. Many pharmacies run a simple potassium blood test if there’s a risk, saving people from dangerous levels before they start showing up as muscle cramps or heartbeat changes.
Education remains a strong line of defense. I encourage folks: don’t rely on memory. Write dosing schedules on a sticky note or use an old-school pillbox to track everything. For caregivers, especially for elders or people with memory lapses, double-checking becomes part of the daily routine.
Drugmakers and regulatory labs keep an eye on new reports of side effects every year. Updated safety sheets often land in pharmacies before they hit news feeds. In practice, most folks can add PSO to their regimen with minimal trouble, as long as they check in with their healthcare team and keep an eye out for changes in lab results or mysterious symptoms.
Navigating new medicines will always take some work, but with clear advice and real-world support, people can tap into modern therapies safely.
| Names | |
| Preferred IUPAC name | potassium (2R,3R,4S,5R,6R)-2,3,4,5,6-pentakis(oxidooxysulfonyl)oxyhexanal |
| Other names |
Sucrose potassium sulfate Sucrose, potassium salt, octasulfate Saccharose potassium sulfate |
| Pronunciation | /pəˈtæsiəm ˈsuːkrəʊs ɒk.təˈsʌl.feɪt/ |
| Identifiers | |
| CAS Number | [59039-89-9] |
| Beilstein Reference | 3113073 |
| ChEBI | CHEBI:53427 |
| ChEMBL | CHEMBL1201657 |
| ChemSpider | 13346611 |
| DrugBank | DB09289 |
| ECHA InfoCard | 17fd34e8-8a1b-4f65-bb8f-5d8a5f107e3d |
| EC Number | 241-991-7 |
| Gmelin Reference | 38732 |
| KEGG | C14298 |
| MeSH | D019356 |
| PubChem CID | 6918203 |
| RTECS number | TC9103000 |
| UNII | 77G6B91K3E |
| UN number | UN3260 |
| CompTox Dashboard (EPA) | DJ7Y6P700U |
| Properties | |
| Chemical formula | C12H22K8O19S8 |
| Molar mass | 816.73 g/mol |
| Appearance | White powder |
| Odor | Odorless |
| Density | 0.8 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -7.6 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 1.2 |
| Basicity (pKb) | pKb: 5.3 |
| Magnetic susceptibility (χ) | -62.0e-6 cm³/mol |
| Viscosity | Viscous liquid |
| Dipole moment | 2.68 D |
| Pharmacology | |
| ATC code | A02XA03 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. |
| Precautionary statements | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. |
| NFPA 704 (fire diamond) | 1-0-1 |
| Lethal dose or concentration | LD50 oral, rat: > 2,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): >2000 mg/kg (oral, rat) |
| PEL (Permissible) | Not established |
| REL (Recommended) | REL: Not established |
| Related compounds | |
| Related compounds |
Sucrose Sucrose sulfate Potassium sulfate Aluminum sucrose octasulfate |
